Facioscapulohumeral dystrophy (FSHD) is an autosomal dominant muscular dystrophy predominantly affecting facial and upper extremity muscles. Hearing loss and retinopathy are frequently observed extramuscular features. FSHD1 is caused by contraction of the D4Z4 macrosatellite repeat to 10 or less D4Z4 units in the subtelomeric region of 4q on the 4A161 haplotype. DUX4 is more efficiently silenced with increasing D4Z4 copy number: human FSHD1 is associated with 1-10 D4Z4 repeat units, whereas the unaffected population has 11-100 D4Z4 repeat units. When expressed in skeletal muscle, the DUX4 transcription factor activates genes normally expressed in the germline (essentially inducing a stem cell program in the postmitotic muscle cell) and also suppresses several genes involved in the innate immune response.

The D4Z4-12.5 transgene has the human subtelomeric region of 4q35 (~130 kbp containing several centromeric genes and 12.5 D4Z4 repeat units [see note below] followed by the haplotype 4A161 pLAM DUX4 exon 3 [with polyA signal]). Hemizygous D4Z4-12.5 mice recapitulate important epigenetic and DUX4 expression attributes seen in human siblings/controls devoid of FSHD1; including moderate-to-high DUX4 expression levels in the germline and sufficient epigenetic repression of DUX4 in somatic tissue. Importantly, the donating investigator reports that resizing efforts in 2015 suggest that D4Z4-12.5 transgenic mice carry an array of 15.5 D4Z4 repeat units.

The phenotype listed below compares the D4Z4-2.5 transgenic mice carrying a D4Z4 genomic region from a contracted pathogenic FSHD1 allele (Stock No. 027991) with the D4Z4-12.5 transgenic mice carrying a normal sized, non-pathogenic allele (Stock No. 028012). Unless noted otherwise, hemizygous mice are described.


The fewer (2.5) D4Z4 repeat units in D4Z4-2.5 mice causes inefficient DUX4 repression in somatic tissue (bodywide hypomethylation of D4Z4) and manifests in features of human FSHD1. In contrast, D4Z4-12.5 mice have a D4Z4 repeat array (12.5) that maintains somatic tissue epigenetic silencing of DUX4 at a low enough level sufficient to preclude FSHD1 phenotype in humans.

D4Z4-2.5 mice have abundant levels of DUX4 mRNA in germ line tissues (most notably in testis), in ES cells and in early developmental stages. In D4Z4-12.5 mice, the pattern is similar but at lower levels.

In adult somatic tissue from D4Z4-2.5 mice, DUX4 mRNA expression is low and variegated in all analyzed skeletal muscles, and a variegated expression pattern of DUX4 protein in skeletal muscle nuclei is observed. In adult somatic tissue from D4Z4-12.5 mice, DUX4 transcripts are reproducibly detected only in the tibialis anterior and pectoralis muscles, whereas all other somatic tissues do not show reproducible DUX4 expression.

D4Z4-2.5 mice exhibit chromatin relaxation of the D4Z4 repeats compared to D4Z4-12.5 mice.

In both D4Z4-2.5 and D4Z4-12.5 mice, the overall morphology/histology of the limb and some head muscles appear normal. Hemizygous mice are viable and fertile. The donating investigator also reports that homozygous mice are viable and fertile, and that the number of D4Z4 repeats within each line stays the same through several generations of breeding (i.e., the D4Z4 repeat unit is stable).

Approximately half of the D4Z4-2.5 mice develop eye abnormalities (keratitis) around 8-12 weeks of age.